FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091246008> ?p ?o ?g. }

• W2091246008 endingPage "471" @default.
• W2091246008 startingPage "461" @default.
• W2091246008 abstract "Angiogenesis, the formation of new blood vessels, is essential for tumor growth. The inhibition of angiogenesis is therefore emerging as a promising therapy for cancer. Two natural products, fumagillin and ovalicin, were discovered to be potent inhibitors of angiogenesis due to their inhibition of endothelial cell proliferation. An analog of fumagillin, AGM-1470, is currently undergoing clinical trials for the treatment of a variety of cancers. The underlying molecular mechanism of the inhibition of angiogenesis by these natural drugs has remained unknown.Both AGM-1470 and ovalicin bind to a common bifunctional protein, identified by mass spectrometry as the type 2 methionine aminopeptidase (MetAP2). This protein also acts as an inhibitor of eukaryotic initiation factor 2alpha (elF-2alpha) phosphorylation. Both drugs potently inhibit the methionine aminopeptidase activity of MetAP2 without affecting its ability to block elF-2alpha phosphorylation. There are two types of methionine aminopeptidase found in eukaryotes, but only the type 2 enzyme is inhibited by the drugs. A series of analogs of fumagillin and ovalicin were synthesized and their potency for inhibition of endothelial cell proliferation and inhibition of methionine aminopeptidase activity was determined. A significant correlation was found between the two activities.The protein MetAP2 is a common molecular target for both AGM-1470 and ovalicin. This finding suggests that MetAP2 may play a critical role in the proliferation of endothelial cells and may serve as a promising target for the development of new anti-angiogenic drugs." @default.
• W2091246008 created "2016-06-24" @default.
• W2091246008 creator A5015479608 @default.
• W2091246008 creator A5022898358 @default.
• W2091246008 creator A5024249610 @default.
• W2091246008 creator A5030090604 @default.
• W2091246008 creator A5041859681 @default.
• W2091246008 creator A5058262240 @default.
• W2091246008 creator A5073462259 @default.
• W2091246008 creator A5081876745 @default.
• W2091246008 date "1997-06-01" @default.
• W2091246008 modified "2023-10-16" @default.
• W2091246008 title "Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin" @default.
• W2091246008 cites W1552225029 @default.
• W2091246008 cites W1554067582 @default.
• W2091246008 cites W1569668268 @default.
• W2091246008 cites W1613879076 @default.
• W2091246008 cites W1679229092 @default.
• W2091246008 cites W1957871175 @default.
• W2091246008 cites W1965116617 @default.
• W2091246008 cites W1966829776 @default.
• W2091246008 cites W1976231761 @default.
• W2091246008 cites W1984636761 @default.
• W2091246008 cites W1985804036 @default.
• W2091246008 cites W1988493500 @default.
• W2091246008 cites W1989141809 @default.
• W2091246008 cites W2005453501 @default.
• W2091246008 cites W2007675240 @default.
• W2091246008 cites W2009240587 @default.
• W2091246008 cites W2010435021 @default.
• W2091246008 cites W2015410008 @default.
• W2091246008 cites W2027444723 @default.
• W2091246008 cites W2027986311 @default.
• W2091246008 cites W2040766532 @default.
• W2091246008 cites W2048402595 @default.
• W2091246008 cites W2078594804 @default.
• W2091246008 cites W2086157929 @default.
• W2091246008 cites W2088054426 @default.
• W2091246008 cites W2102522131 @default.
• W2091246008 cites W2129034847 @default.
• W2091246008 cites W2135842532 @default.
• W2091246008 cites W2146916102 @default.
• W2091246008 cites W2157982789 @default.
• W2091246008 cites W2158743409 @default.
• W2091246008 cites W2166080631 @default.
• W2091246008 cites W2292329499 @default.
• W2091246008 cites W2312432821 @default.
• W2091246008 cites W2320445268 @default.
• W2091246008 cites W4211002736 @default.
• W2091246008 cites W86948232 @default.
• W2091246008 doi "https://doi.org/10.1016/s1074-5521(97)90198-8" @default.
• W2091246008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9224570" @default.
• W2091246008 hasPublicationYear "1997" @default.
• W2091246008 type Work @default.
• W2091246008 sameAs 2091246008 @default.
• W2091246008 citedByCount "389" @default.
• W2091246008 countsByYear W20912460082012 @default.
• W2091246008 countsByYear W20912460082013 @default.
• W2091246008 countsByYear W20912460082014 @default.
• W2091246008 countsByYear W20912460082015 @default.
• W2091246008 countsByYear W20912460082016 @default.
• W2091246008 countsByYear W20912460082017 @default.
• W2091246008 countsByYear W20912460082018 @default.
• W2091246008 countsByYear W20912460082019 @default.
• W2091246008 countsByYear W20912460082020 @default.
• W2091246008 countsByYear W20912460082021 @default.
• W2091246008 countsByYear W20912460082022 @default.
• W2091246008 countsByYear W20912460082023 @default.
• W2091246008 crossrefType "journal-article" @default.
• W2091246008 hasAuthorship W2091246008A5015479608 @default.
• W2091246008 hasAuthorship W2091246008A5022898358 @default.
• W2091246008 hasAuthorship W2091246008A5024249610 @default.
• W2091246008 hasAuthorship W2091246008A5030090604 @default.
• W2091246008 hasAuthorship W2091246008A5041859681 @default.
• W2091246008 hasAuthorship W2091246008A5058262240 @default.
• W2091246008 hasAuthorship W2091246008A5073462259 @default.
• W2091246008 hasAuthorship W2091246008A5081876745 @default.
• W2091246008 hasBestOaLocation W20912460081 @default.
• W2091246008 hasConcept C2776056115 @default.
• W2091246008 hasConcept C2776309324 @default.
• W2091246008 hasConcept C2776580952 @default.
• W2091246008 hasConcept C2780394083 @default.
• W2091246008 hasConcept C2780912031 @default.
• W2091246008 hasConcept C2780985610 @default.
• W2091246008 hasConcept C502942594 @default.
• W2091246008 hasConcept C515207424 @default.
• W2091246008 hasConcept C55493867 @default.
• W2091246008 hasConcept C62112901 @default.
• W2091246008 hasConcept C86803240 @default.
• W2091246008 hasConcept C98274493 @default.
• W2091246008 hasConceptScore W2091246008C2776056115 @default.
• W2091246008 hasConceptScore W2091246008C2776309324 @default.
• W2091246008 hasConceptScore W2091246008C2776580952 @default.
• W2091246008 hasConceptScore W2091246008C2780394083 @default.
• W2091246008 hasConceptScore W2091246008C2780912031 @default.
• W2091246008 hasConceptScore W2091246008C2780985610 @default.
• W2091246008 hasConceptScore W2091246008C502942594 @default.
• W2091246008 hasConceptScore W2091246008C515207424 @default.

• next